Envoplakin Antikörper
-
- Target Alle Envoplakin (EVPL) Antikörper anzeigen
- Envoplakin (EVPL)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Envoplakin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Purified by antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Top Product
- Discover our top product EVPL Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for up to one year. Avoid repeated freeze/thaw cycles.
-
- Target
- Envoplakin (EVPL)
- Andere Bezeichnung
- Envoplakin (EVPL Produkte)
- Synonyme
- EVPL antikoerper, evpk antikoerper, wu:fb17b09 antikoerper, evpl antikoerper, sb:cb742 antikoerper, si:ch211-157f15.1 antikoerper, EVPK antikoerper, envoplakin antikoerper, envoplakin b antikoerper, envoplakin a antikoerper, envoplakin L homeolog antikoerper, EVPL antikoerper, Evpl antikoerper, evpl antikoerper, evplb antikoerper, evpla antikoerper, evpl.L antikoerper
-